ator 20 mg 10 f.c.tabs

Ator medication is a treatment used to reduce the level of bad cholesterol in the blood, which helps in preventing heart diseases and atherosclerosis. Ator helps improve heart health by lowering bad cholesterol and increasing good cholesterol.

What are the components of Ator?

Ator contains the following components:

• Active ingredient: Atorvastatin.
• Inactive ingredients that help stabilize and formulate the medication.

Uses of Ator

Ator is primarily used in the following cases:

• Lowering levels of bad cholesterol (LDL).
• Reducing triglyceride levels in the blood.
• Increasing levels of good cholesterol (HDL).
• Preventing heart diseases and atherosclerosis.
• Reducing the risk of heart attacks and strokes.

What are the doses of Ator?

The doctor determines the appropriate dose for each patient based on their health condition and cholesterol levels. Typical doses range from 10 mg to 80 mg once daily.

What are the side effects of Ator?

Some side effects may occur when using Ator, including:

• Headache.
• Muscle or joint pain.
• Digestive disturbances such as nausea or diarrhea.
• Elevated liver enzymes.
• General fatigue.

Author Name: Pharmacist Nada Mohamed Mostafa

Scientific Degree: Pharmacist

Country: Egypt

Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

Published Date: 16 May 2025